Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term clinical outcome after fractional flow reserve- versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts.
Di Serafino L, De Bruyne B, Mangiacapra F, Bartunek J, Agostoni P, Vanderheyden M, Scognamiglio G, Heyndrickx GR, Wijns W, Barbato E. Di Serafino L, et al. Among authors: agostoni p. Am Heart J. 2013 Jul;166(1):110-8. doi: 10.1016/j.ahj.2013.04.007. Epub 2013 May 16. Am Heart J. 2013. PMID: 23816029
Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G. Vermeersch P, et al. Among authors: agostoni p. J Am Coll Cardiol. 2006 Dec 19;48(12):2423-31. doi: 10.1016/j.jacc.2006.09.021. Epub 2006 Nov 28. J Am Coll Cardiol. 2006. PMID: 17174178 Free article. Clinical Trial.
Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
Agostoni P, Vermeersch P, Semeraro O, Verheye S, Van Langenhove G, Van den Heuvel P, Convens C, Van den Branden F, Bruining N. Agostoni P, et al. Am J Cardiol. 2007 Jul 1;100(1):52-8. doi: 10.1016/j.amjcard.2007.02.052. Epub 2007 May 11. Am J Cardiol. 2007. PMID: 17599440 Clinical Trial.
Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G; DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Vermeersch P, et al. Among authors: agostoni p. J Am Coll Cardiol. 2007 Jul 17;50(3):261-7. doi: 10.1016/j.jacc.2007.05.010. Epub 2007 Jun 13. J Am Coll Cardiol. 2007. PMID: 17631219 Free article. Clinical Trial.
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.
Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I. Biondi-Zoccai GG, et al. Among authors: agostoni p. Am Heart J. 2008 Feb;155(2):274-83. doi: 10.1016/j.ahj.2007.10.009. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18215597 Review.
Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: clinical results and multiple outcome predictors.
Sangiorgi G, Romagnoli E, Biondi-Zoccai G, Margheri M, Tamburino C, Barbagallo R, Falchetti E, Vittori G, Agostoni P, Cosgrave J, Colombo A; RECIPE (Real-world Eluting-stent Comparative Italian retrosPective Evaluation) Study Investigators. Sangiorgi G, et al. Among authors: agostoni p. Am Heart J. 2008 Nov;156(5):871-8. doi: 10.1016/j.ahj.2008.06.030. Epub 2008 Sep 16. Am Heart J. 2008. PMID: 19061700
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. Verheye S, et al. Among authors: agostoni p. J Am Coll Cardiol. 2009 Mar 24;53(12):1031-9. doi: 10.1016/j.jacc.2008.12.012. J Am Coll Cardiol. 2009. PMID: 19298915 Free article. Clinical Trial.
The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic).
Verheye S, Sarno G, Müller R, Birkemeyer R, Vrints C, Jung W, Agostoni P, van Langenhove G, Haine S, Willems T, Haude M, Grube E, Wijns W. Verheye S, et al. Among authors: agostoni p. EuroIntervention. 2009 Jun;5(2):233-8. doi: 10.4244/eijv5i2a36. EuroIntervention. 2009. PMID: 19527981 Clinical Trial.
917 results